{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-079361","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2025-08-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.492673+00:00","generated_at":"2026-05-17T10:44:42.523876+00:00","sec_items":["5.02","5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Oramed shareholders approve 2M-share increase to 2019 stock incentive plan at annual meeting","bullets":["Shareholders approved amendment to 2019 Stock Incentive Plan, increasing authorized shares by 2M to 9.5M shares.","All seven director nominees re-elected; votes ranged from 12.5M to 13.0M for, with broker non-votes of ~6.4M.","Auditor Kesselman & Kesselman (PwC Israel) ratified for FY2025 with 19.4M for, 1.4M against."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-079361","json":"https://secwatch.observer/filing/0001213900-25-079361.json","markdown":"https://secwatch.observer/filing/0001213900-25-079361.md","text":"https://secwatch.observer/filing/0001213900-25-079361.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025079361/0001213900-25-079361-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025079361/ea0254007-8k_oramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T10:44:42.523876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}